Antibody induced T cell-mediated neonatal autoimmunity.
抗体诱导 T 细胞介导的新生儿自身免疫。
基本信息
- 批准号:8206614
- 负责人:
- 金额:$ 37.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-12-15 至 2013-12-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAddressAdoptive TransferAdultAffectAgeAleuritesAntibodiesAntigen-Antibody ComplexAutoantibodiesAutoimmune DiseasesAutoimmune ProcessAutoimmunityCD4 Positive T LymphocytesCD94 AntigenCell physiologyComplexCytolysisDendritic CellsDiseaseDisease modelEquilibriumEventFrequenciesGenesGoalsGrantGrowthIL2RA geneImmune responseImmune systemInflammatoryInfusion proceduresInjuryInterleukin-10InvestigationKnockout MiceLifeLigandsMediatingModelingMusNatural ImmunityNatural Killer CellsNeonatalOocytesOrganOvarianOvarian DiseasesOvaryPathogenesisPhysiologyPlayPredisposing FactorProcessRegulationRegulatory T-LymphocyteRelative (related person)Research PersonnelResistanceRheumatoid ArthritisRoleSeminalSpecificityT cell responseT-LymphocyteTestingTimeWild Type MouseWorkbasecytokineinsightknockout geneneonatenovelperforinprogramsreceptorrecombinaseresponsezona pellucida glycoprotein
项目摘要
This is the competitive renewal application to extend our work supported by AI51420-01A. Significant
progress has been made that greatly elucidate the mechanism of the unique neonatal autoimmune ovarian
disease (nAOD). Autoantibody (Ab) to the ovarian ZP3 led to the formation of ovarian immune complex.
This provokes an organ specific autoimmune disease that is regulated by FcgR+, and dependent on de novo
activation of pathogenic CD4 T cells (TD-nAOD). Uniquely, nAOD affects only neonatal mice and spares
mice beyond 5 days of age; therefore, the understanding neonatal propensity to autoimmunity is our major
goal. We discovered that severe nAOD is also induced in the recombinase activating gene (RAG) knockout
(KO) mice, thus innate immunity alone is also sufficient to induce nAOD (TI-nAOD). NK cells play multiple
and pivotal roles in TI-nAOD. A seminal observation is the ontogenetic regulation of NK cell function in TI-
nAOD. RAG KO mice deficient in perforin did not develop TI-nAOD, and the disease was restored by
neonatal but not adult (or day 9) NK cells from wild type donors. NK function in TI-nAOD also depended on
NKG2D - a major NK cell activating receptor. In AIM 1, we will test the hypothesis that the late ontogeny of
expression of the Ly49 NK cell inhibitory receptors allows neonatal NK cells to escape from regulation
between neonatal 1-5 days, and to induce neonatal ovarian injury. The pro-inflammatory cytokine IFNg and
also FcgR played non-redundant roles in the pathogenesis of both TI-nAOD and TD-nAOD. In AIM 2, we will
investigate the cellular basis for the IFNg- and NK cell- dependent functions in TI-nAOD of RAG KO mice.
And in AIM 3, we will investigate how neonatal NK cells and IFNg promote de novo pathogenic T cell
responses in TD-nAOD of wild type mice; in particular, determine the relative contribution of NK cells and
dendritic cells in this process. Finally, the NK cell-dependent TI-nAOD was readily suppressed by adult
CD4+CD25+ Treg, and it requires IL10. This finding documents, for the first time, Treg suppression of any
form of neonatal immune response. In AIM 4, we will investigate the cellular mechanism of the IL10-
dependent Treg suppression. Also, by comparing the mechanism of suppression between the adult and the
neonatal hosts, we expect to obtain new insight into the physiology of neonatal immune system, and further
elucidate the important observation of neonatal propensity to autoimmune disease.
这是 AI51420-01A 支持的竞争性续订应用程序,用于扩展我们的工作。重要的
已取得的进展极大地阐明了独特的新生儿自身免疫性卵巢的机制
疾病(nAOD)。卵巢 ZP3 的自身抗体 (Ab) 导致卵巢免疫复合物的形成。
这会引发一种器官特异性自身免疫性疾病,该疾病受 FcgR+ 调节,并依赖于 de novo
致病性 CD4 T 细胞 (TD-nAOD) 的激活。独特的是,nAOD 仅影响新生小鼠和备件
5日龄以上的小鼠;因此,了解新生儿的自身免疫倾向是我们的主要任务
目标。我们发现重组酶激活基因 (RAG) 敲除也会诱导严重的 nAOD
(KO) 小鼠,因此仅先天免疫也足以诱导 nAOD (TI-nAOD)。 NK细胞发挥多种作用
并在 TI-nAOD 中发挥关键作用。一个开创性的观察是 TI-中 NK 细胞功能的个体发育调控
nAOD。缺乏穿孔素的 RAG KO 小鼠没有出现 TI-nAOD,并且通过以下方法使疾病恢复:
来自野生型供体的新生儿而非成人(或第 9 天)NK 细胞。 TI-nAOD 中的 NK 功能还取决于
NKG2D - 一种主要的 NK 细胞激活受体。在 AIM 1 中,我们将检验以下假设:个体发育晚期
Ly49 NK 细胞抑制性受体的表达使新生儿 NK 细胞逃避调控
新生儿1-5天之间,诱发新生儿卵巢损伤。促炎细胞因子 IFNg 和
FcgR 在 TI-nAOD 和 TD-nAOD 的发病机制中也发挥着非冗余的作用。在 AIM 2 中,我们将
研究 RAG KO 小鼠 TI-nAOD 中 IFNg 和 NK 细胞依赖性功能的细胞基础。
在 AIM 3 中,我们将研究新生儿 NK 细胞和 IFNg 如何促进新生致病性 T 细胞
野生型小鼠 TD-nAOD 的反应;特别是,确定 NK 细胞的相对贡献和
树突状细胞在此过程中。最后,NK 细胞依赖性 TI-nAOD 很容易被成人抑制
CD4+CD25+Treg,需要IL10。这一发现首次证明了 Treg 抑制任何
新生儿免疫反应的形式。在 AIM 4 中,我们将研究 IL10-的细胞机制
依赖性 Treg 抑制。此外,通过比较成人和成人之间的抑制机制
新生儿宿主,我们期望获得对新生儿免疫系统生理学的新见解,并进一步
阐明新生儿自身免疫性疾病倾向的重要观察结果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KENNETH S.K. TUNG其他文献
KENNETH S.K. TUNG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KENNETH S.K. TUNG', 18)}}的其他基金
Regulatory and effector T cells in SLE
SLE 中的调节性 T 细胞和效应性 T 细胞
- 批准号:
6663943 - 财政年份:2002
- 资助金额:
$ 37.12万 - 项目类别:
Antibody induced T cell mediated neonatal autoimmunity
抗体诱导 T 细胞介导的新生儿自身免疫
- 批准号:
6825714 - 财政年份:2002
- 资助金额:
$ 37.12万 - 项目类别:
Autoimmune Oophoritis: Consequences of Gamete Vaccines
自身免疫性卵巢炎:配子疫苗的后果
- 批准号:
6667129 - 财政年份:2002
- 资助金额:
$ 37.12万 - 项目类别:
Autoimmune Oophoritis: Consequences of Gamete Vaccines
自身免疫性卵巢炎:配子疫苗的后果
- 批准号:
6847457 - 财政年份:2002
- 资助金额:
$ 37.12万 - 项目类别:
Antibody induced T cell mediated neonatal autoimmunity
抗体诱导 T 细胞介导的新生儿自身免疫
- 批准号:
6983362 - 财政年份:2002
- 资助金额:
$ 37.12万 - 项目类别:
Antibody induced T cell mediated neonatal autoimmunity
抗体诱导 T 细胞介导的新生儿自身免疫
- 批准号:
6575358 - 财政年份:2002
- 资助金额:
$ 37.12万 - 项目类别:
Antibody-induced T cell-mediated neonatal autoimmunity
抗体诱导的 T 细胞介导的新生儿自身免疫
- 批准号:
6463504 - 财政年份:2002
- 资助金额:
$ 37.12万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 37.12万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 37.12万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 37.12万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 37.12万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 37.12万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 37.12万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 37.12万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 37.12万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 37.12万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 37.12万 - 项目类别:
Research Grant














{{item.name}}会员




